Tag Archives: Meiji Pharmaceutical University

omiRas – A MicroRNA-Seq Data Analysis Pipeline


To identify circulating miRNA biomarkers for AD, researchers from Meiji Pharmaceutical University, Japan reanalyzed a publicly available small RNA-Seq dataset, composed of blood samples derived from 48 AD patients and 22 normal control (NC) subjects, by a simple web-based miRNA ...

Read More »